ISIS PHARMACEUTICALS INC DEL's ticker is and the CUSIP is 464337AJ3. A total of 49 filers reported holding ISIS PHARMACEUTICALS INC DEL in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,992,000 | -4.0% | 1,900 | 0.0% | 0.02% | +6.2% |
| Q4 2020 | $2,074,000 | -4.3% | 1,900 | -9.5% | 0.02% | -20.0% |
| Q3 2020 | $2,167,000 | -6.6% | 2,100 | 0.0% | 0.02% | -16.7% |
| Q2 2020 | $2,320,000 | -5.9% | 2,100 | -4.5% | 0.02% | -11.1% |
| Q1 2020 | $2,465,000 | -2.3% | 2,200 | 0.0% | 0.03% | 0.0% |
| Q4 2019 | $2,522,000 | +85.9% | 2,200 | +120.0% | 0.03% | +58.8% |
| Q1 2019 | $1,357,000 | +25.9% | 1,000 | 0.0% | 0.02% | 0.0% |
| Q4 2018 | $1,078,000 | +2.1% | 1,000 | 0.0% | 0.02% | +21.4% |
| Q3 2018 | $1,056,000 | +7.5% | 1,000 | 0.0% | 0.01% | -12.5% |
| Q2 2018 | $982,000 | – | 1,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TENOR CAPITAL MANAGEMENT Co., L.P. | 74,881,000 | $76,559,000 | 1.97% |
| III Capital Management | 15,000,000 | $15,227,000 | 1.82% |
| TFG Asset Management GP Ltd | 14,055,000 | $14,321,000 | 1.02% |
| MACKAY SHIELDS LLC | 28,304,000 | $28,739,000 | 0.21% |
| RWC Asset Management LLP | 6,500,000 | $6,604,000 | 0.20% |
| PALISADE CAPITAL MANAGEMENT, LP | 7,187,000 | $7,281,000 | 0.17% |
| CQS (US), LLC | 4,000,000 | $4,092,000 | 0.13% |
| FARALLON CAPITAL MANAGEMENT LLC | 24,435,000 | $24,797,000 | 0.12% |
| D. E. Shaw & Co., Inc. | 59,728,000 | $60,845,000 | 0.06% |
| BNP Paribas Asset Management Holding S.A. | 7,000,000 | $7,133,000 | 0.03% |